Diseases, Conditions, Syndromes

Adding tirzepatide to insulin glargine ups glycemic control in T2DM

(HealthDay)—The addition of subcutaneous tirzepatide versus placebo to titrated insulin glargine results in significant improvements in glycemic control among patients with type 2 diabetes and inadequate glycemic control, ...

Medical research

Novel cancer therapy extends lives of terminally ill dogs

Dogs are humans' best friends and it is always distressing for dog owners when their beloved pets contract terminal illnesses. Canine cancer is the leading cause of death in dogs and when they are diagnosed with late-stage ...

page 11 from 40